Anika Therapeutics Reports Fourth Quarter and Full Year 2012 Financial Results

Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid (“HA”) technology, today reported financial results for the quarter and full year ended December 31, 2012. The company generated record quarterly and full year revenue in 2012.

MORE ON THIS TOPIC